NCT06478732View on ClinicalTrials.gov

HeartMed-HF Digital Therapeutics Improves Exercise Capacity in CHF Patients After AMI

NANot yet recruitingINTERVENTIONAL
Enrollment

710

Participants

Timeline

Start Date

July 30, 2024

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
Heart Failure
Interventions
OTHER

health services

Implement comprehensive heart failure management for patients in the experimental group using the HeartMed-HF digital therapy

All Listed Sponsors
lead

The First Affiliated Hospital with Nanjing Medical University

OTHER

NCT06478732 - HeartMed-HF Digital Therapeutics Improves Exercise Capacity in CHF Patients After AMI | Biotech Hunter | Biotech Hunter